InTech Partners with the American Society for Exosomes and Microvesicles to Publish Exosomes and Microvesicles Journal, an Open Access Publication - PR Newswire - The Sacramento Bee

"InTech Open Access publisher is pleased to announce the collaboration with the American Society for Exosomes and Microvesicles (ASEMV) to publish the scientific journal Exosomes and Microvesicles, a peer-reviewed publication designed to bring together exosomes principles, scientific research and clinical applications. The Exosomes and Microvesicles journal is one of the first publications to focus exclusively on this subject matter, which has important implications for treating diseases such as cancer. Despite the past decade's explosion of research within the fields of exosomes, microvesicles and other extracellular vesicles, access to this data is often limited – thus impacting further advancements in human health. As the official journal of the ASEMV, Exosomes and Microvesicles will provide open access to global data, supporting the organization's mission to advance extracellular vesicle research and support the scientists, institutions and laboratories working in this field. 'The goal of Exosomes and Microvesicles is to connect scientists, clinicians and industry-based researchers, enhancing the translation of exosomes and their biology into clinical trials,' said Douglas Taylor, ASEMV Secretary-General and Exosomes and Microvesicles editor. 'No other current journal focuses on the application of exosomes in the maintenance of health and development of disease.'  Exosomes and Microvesicles editors include experts and leaders in these research fields, who provide peer-review for all data submitted to the journal. Exosomes and Microvesicles' promise of excellence is evident in its Associate Editors and members of its Editorial Board: international experts with diverse expertise mirroring the journal's scope ... 'As part of the launch of Exosomes and Microvesicles, InTech and ASEMV are currently waiving all submission fees for potential authors,' said Winston Patrick Kuo, Harvard Medical School andExosomes and Microvesicles editor. 'Our goal is to remove access barriers to new, important research and globalize the scientific dialog. Through this new journal and its open access platform, we hope to provide the science community an international connection to cutting-edge research and potential new health solutions.' ... "